Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AMGN

AMGEN Inc

410.95

Aug 07 • 3:59 PM ET +6.10 (1.51%)

410.92

Aftermarket • 7:09 PM ET -0.02 (-0.01%)

Healthcare Drug Manufacturers - General USA Mega NASD

Peers: GILD LLY MRK ABBV PFE JNJ BMY REGN VRTX BIIB

| Held by: VTI VOO SCHD QQQ IVV SPY DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500
Market Cap	222.17B
Enterprise Value	265.49B
Income	8.74B
Sales	38.20B
Book/sh	21.62
Cash/sh	25.88
Dividend Est.	10.10 (2.46%)
Dividend TTM	9.80 (2.38%)
Dividend Ex-Date	Aug 21, 2026
Dividend Gr. 3/5Y	7.05% 8.27%
Payout	66.92%
Employees	31500
IPO	Jun 17, 1983

P/E	25.53
Forward P/E	17.03
PEG	3.38
P/S	5.82
P/B	19.01
P/C	15.88
P/FCF	21.83
EV/EBITDA	15.26
EV/Sales	6.95
Quick Ratio	1.13
Current Ratio	1.37
Debt/Eq	4.90
LT Debt/Eq	4.44
Option/Short	Yes / Yes

EPS (ttm)	16.10
EPS next Y	24.13
EPS next Q	5.81
EPS this Y	4.95%
EPS next Y	5.28%
EPS next 5Y	5.04%
EPS past 3/5Y	5.51% 2.93%
Sales past 3/5Y	12.09% 7.79%
EPS Y/Y TTM	31.69%
Sales Y/Y TTM	9.89%
EPS Q/Q	64.93%
Sales Q/Q	9.82%
Earnings	Aug 04 AMC
EPS/Sales Surpr.	11.97% 6.66%

Insider Own	0.23%
Insider Trans	-4.89%
Inst Own	81.82%
Inst Trans	-1.91%
ROA	9.53%
ROE	91.47%
ROIC	13.76%
Gross Margin	72.71%
Oper. Margin	33.31%
Profit Margin	22.89%
SMA20	8.45%
SMA50	13.53%
SMA200	18.65%
Trades

Shs Outstand	540.60M
Shs Float	539.40M
Short Float	2.38%
Short Ratio	4.67
Short Interest	12.85M
52W High	418.40 -1.78%
52W Low	269.77 52.33%
Volatility	4.27% 2.89%
ATR (14)	11.86
RSI (14)	72.07
Beta	0.42
Rel Volume	0.66
Avg Volume	2.75M
Volume	1,821,551

Perf Week	6.69%
Perf Month	13.01%
Perf Quarter	24.87%
Perf Half Y	11.73%
Perf YTD	25.55%
Perf Year	44.34%
Perf 3Y	62.47%
Perf 5Y	78.56%
Perf 10Y	136.64%
Recom	2.43
Target Price	380.33
Prev Close	404.85
Price	410.95
Change %	1.51%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-26	Reiterated	Wells Fargo	Equal Weight	$390 → $400
Aug-05-26	Reiterated	Truist	Hold	$340 → $362
Aug-05-26	Reiterated	Robert W. Baird	Underperform	$215 → $230
Aug-05-26	Reiterated	RBC Capital Mkts	Outperform	$370 → $400
Aug-05-26	Reiterated	Oppenheimer	Outperform	$400 → $450
Aug-05-26	Reiterated	Morgan Stanley	Equal-Weight	$333 → $351
Aug-05-26	Reiterated	Canaccord Genuity	Hold	$366 → $384
Aug-05-26	Reiterated	BofA Securities	Underperform	$312 → $317
Aug-05-26	Reiterated	BMO Capital Markets	Outperform	$400 → $450
May-05-26	Downgrade	Erste Group	Buy → Hold
Apr-21-26	Initiated	Canaccord Genuity	Hold	$366
Mar-10-26	Initiated	Jefferies	Hold	$350
Feb-20-26	Initiated	Barclays	Equal Weight	$185
Jan-20-26	Downgrade	Bernstein	Outperform → Mkt Perform	$335
Jan-07-26	Resumed	UBS	Buy	$380
Dec-05-25	Upgrade	Erste Group	Hold → Buy
Nov-24-25	Resumed	Truist	Hold	$318
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$385
Sep-03-25	Resumed	Raymond James	Mkt Perform
May-20-25	Resumed	Guggenheim	Neutral	$288

Show Previous Ratings

Aug-07-26 02:38PM	The Two Divergent Paths Priced Into Eli Lilly Stock (Trefis)
12:36PM	Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. (Barrons.com)
Aug-05-26 04:54PM	Amgen Stock Climbs as Drug Growth Outruns Obesity Setback (GuruFocus.com)
04:09PM	Dow Makes More New Highs Despite AI Drag: Stock Market Today (Kiplinger)
04:08PM	Dow rallies to another record, but S&P 500 and Nasdaq close in the red (MarketWatch)
01:25PM	Loading…
01:25PM	Amgen gains after strong quarterly results and continued product momentum (Proactive)
12:44PM	Why the Dow Is Outperforming Today (Barrons.com)
11:51AM	Dow's 439-point rally led by gains for Amgen, NVIDIA Corp. shares (MarketWatch)
10:50AM	Amgen, NVIDIA Corp. share gains lead Dow's 650-point rally (MarketWatch)
09:45AM	Dow's 500-point rally led by gains in Amgen, NVIDIA Corp. shares (MarketWatch)
09:30AM	Amgen is raising its outlook after beating earnings and dropping a weight loss drug (Quartz)
09:22AM	Amgen Q2 2026 earnings beat, raises full-year outlook, drops AMG 513 (Quartz)
01:17AM	Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive (Stocktwits)
01:06AM	Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ... (GuruFocus.com)
Aug-04-26 04:14PM	Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment (The Wall Street Journal)
04:06PM	Loading…
04:06PM	Amgen Hikes Sales Outlook By $1 Billion After Second-Quarter Smash (Investor's Business Daily)
04:05PM	Amgen: Q2 Earnings Snapshot (Associated Press)
04:01PM	AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS (PR Newswire)
Aug-03-26 01:00PM	Amgen contends with data breach, exposing patient information (Pharmaceutical Technology)
Jul-31-26 10:26AM	The Signs Before Eli Lilly Stock Surged Were All On The Record (Trefis)
10:07AM	LLY Stock: Collect 12% Now, In Exchange For Capping Upside At 15% (Trefis)
Jul-30-26 04:01PM	AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND (PR Newswire)
06:36AM	Amgen's Repatha receives positive CHMP opinion for broader cardiovascular use (Pharmaceutical Business Review)
Jul-29-26 03:27PM	The Week Ahead: Jobs Data, Top 10 Earnings Reports to Watch (Schaeffer's Research)
09:00AM	POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA BEFORE A FIRST HEART ATTACK OR STROKE (PR Newswire)
06:02AM	Biogen Raises Earnings Guidance as Growth Portfolio Outpaces Legacy Blockbuster Drugs (Barrons.com)
Jul-28-26 04:45PM	AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS (PR Newswire)
04:41PM	Does Eli Lilly Stock Actually Diversify Your Portfolio? (Trefis)
07:45AM	Nasdaq 100 enters correction as sell-off deepens, while Coke and Sherwin-Williams lead Dow (Proactive)
02:16AM	FTSE 100 Live: Unilever leads index close to highs, US semi sell-off deepens (Proactive)
02:33PM	Loading…
Jul-27-26 02:33PM	Collect 9.8% On LLY Stock Now, Own It 30% Cheaper If It Dips (Trefis)
06:16AM	Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO (BioPharma Dive)
Jul-24-26 07:35AM	Sanofi halts development of troubled immune drug in eczema (BioPharma Dive)
Jul-22-26 09:17AM	LLY Has Momentum. The Question Is The Price (Trefis)
Jul-21-26 04:04PM	Eli Lilly Stock And The Price Of Confidence (Trefis)
Jul-20-26 01:45PM	Eli Lilly Stock And The Price Of Confidence (Trefis)
08:17AM	Merck's Keytruda Faces a Patent Cliff. These New Cancer Drugs Could Take Over. (Barrons.com)
02:00AM	What Comes After Merck's Keytruda? The Race for the Next Standard Cancer Treatment. (Barrons.com)
Jul-17-26 09:09AM	Seagate Stock And The Bet On A Denser Future (Trefis)
08:02AM	Fortinet Stock Is Pricing In A Much Bigger Future (Trefis)
06:39AM	The weight-loss drugs boom is creating both winners and wipeouts: One Big Investment Idea (Yahoo Finance)
Jul-16-26 11:45AM	Eli Lilly is acquiring psychedelic drug developer AtaiBeckley for $3.8 billion (Yahoo Finance Video)
09:19AM	What Could Push LLY Stock Higher From Here? (Trefis)
09:13AM	Dow Jones' Merck Snags A First-Of-Its-Kind Approval, And Jumps (Investor's Business Daily)
08:17AM	Merck Stock Rises After U.S. Approval for Powerful Cholesterol-Cutting Pill (Barrons.com)
06:45AM	Merck Gets Approval for Powerful Cholesterol-Cutting Pill (Barrons.com)
Jul-14-26 01:54PM	What Lilly's Peer-Beating Numbers Cost You (Trefis)
11:24AM	What If the Car Is No Longer the Point For Tesla Stock? (Trefis)
Jul-13-26 01:37PM	Own Regeneron For Biotech Growth? Incyte Is Making Its Case. (Trefis)
09:12AM	How Does LLY Stock Reach $2,100? (Trefis)
02:19AM	FTSE 100 Live: Stocks flat as Trump says US to be 'guardian of Hormuz strait' (Proactive)
Jul-09-26 10:58AM	Make Your AMGN Shares Pay You 8.7% While You Hold Them (Trefis)
Jul-08-26 11:36AM	The Wide Divide Ahead For Eli Lilly Stock (Trefis)
Jul-06-26 04:23PM	What Eli Lilly Stock Said When It Had Too Much Business (Trefis)
12:00PM	The Cancer Therapy Strategy VERAXA Is Betting the Company On (Exec Edge)
10:09AM	Nike, Amgen share losses lead Dow's 238-point drop (MarketWatch)
07:59AM	Nasdaq starts strong as 'Trump accounts' launch, Dow dragged down (Proactive)
02:17AM	FTSE 100 Live: Stocks slide despite airlines and defence gains, Microsoft slashes jobs (Proactive)
Jul-02-26 06:19AM	Roche KRAS drug succeeds in head-to-head lung cancer study (BioPharma Dive)
01:50AM	Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial (The Wall Street Journal)
Jul-01-26 04:56PM	Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel (Reuters)
07:06AM	Medical journal retracts Tavneos pivotal paper amid wider regulatory clampdown (Clinical Trials Arena)
Jun-30-26 12:28PM	Amgen Faces Fresh Pressure After NEJM Retracts Trial Behind $459 Million Drug (GuruFocus.com)
07:33AM	Viridian may have edge over Amgen in eye drug showdown, analysts argue (BioPharma Dive)
Jun-29-26 01:37PM	Should You Chase The Breakout In Eli Lilly Stock? (Trefis)
Jun-26-26 08:26AM	European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked (The Wall Street Journal)
Jun-25-26 02:20AM	FTSE 100 Live: Stocks hit record highs on both sides of pond (Proactive)
Jun-22-26 03:47PM	Abbvie acquiring Apogee for $10.9B, Coca-Cola vs. IRS in appeals court (Yahoo Finance Video)
08:46AM	Dow Jones opens higher but Nasdaq flat as hawkish Fed still looms (Proactive)
Jun-18-26 08:56PM	How One Partnership Profit Line Reframes The Regeneron Pharmaceuticals Stock Story (Trefis)
04:57PM	What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine? (Trefis)
11:52AM	Here's what's weighing on the Dow today (MarketWatch)
Jun-17-26 02:21PM	Eli Lilly Stock's Trillion-Dollar Question (Trefis)
12:39PM	Vedana debuts with $46m to progress migraine therapies (Pharmaceutical Technology)
11:57AM	Everyone Is Watching Eli Lilly Stock's New Drugs. Here Is the Metric That Vanished (Trefis)
Jun-12-26 01:31PM	The Catch Hiding In Eli Lilly Stock's Growth Story (Trefis)
09:09AM	Amgen's $500 Million Tavneos Faces FDA Withdrawal Fight (GuruFocus.com)
Jun-11-26 03:24PM	Dow's gain builds, toward biggest point rise in two months (MarketWatch)
03:15PM	Dow up 889 points on gains for shares of Honeywell, Amgen (MarketWatch)
02:14PM	Dow's 750-point rally led by gains in shares of Amgen, Boeing (MarketWatch)
01:13PM	Amgen, Honeywell share gains lead Dow's 265-point jump (MarketWatch)
12:12PM	Caterpillar, Amgen share gains lead Dow's 414-point jump (MarketWatch)
09:46AM	Dow rallies 288 points on gains for Amgen, Caterpillar shares (MarketWatch)
08:37AM	Nasdaq semis stocks lead rebound rally despite Trump warning of new Iran strikes (Proactive)
03:00AM	Takedas $4B TYK2 drug tops Bristol Myers Sotyktu in head-to-head test (BioPharma Dive)
Jun-09-26 01:29PM	All 30 Dow Jones Stocks Ranked: Buy, Sell or Hold? (Kiplinger)
Jun-08-26 03:49PM	Why Is Lilly Stock Growing Like A Silicon Valley Tech Darling? (Trefis)
09:07AM	Can MariTide Save Amgen Stock From Its Fading Blockbusters? (Trefis)
Jun-07-26 04:45PM	AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS (PR Newswire)
Jun-05-26 06:55PM	Is Amgen An Undervalued Stock Or Value Trap? (Trefis)
Jun-04-26 04:23PM	75% Upside For LLY Stock? (Trefis)
04:21PM	Quantinuum Shares Pare Gains to Close Little Changed After IPO (Bloomberg)
04:01PM	AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Jun-03-26 09:00AM	AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026 (PR Newswire)
Jun-02-26 11:28AM	ASCO 2026: Mixed SCLC result for Legends LB2102, Novartis expedites manufacture (Pharmaceutical Technology)
Jun-01-26 04:00PM	EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER (PR Newswire)
07:17AM	MIT bullish on its Initiative for New Manufacturing at the one-year mark (Manufacturing Dive)
May-29-26 04:01PM	AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
May-27-26 12:00PM	A New, Powerful Cholesterol-Lowering Drug Is on the Horizon (The Wall Street Journal)
09:00AM	Ember LifeSciences announces new strategic investments boosting Series A to $27M (PR Newswire)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Chairman & CEOMr. Robert A. Bradway

Executive VP & CFOMr. Peter H. Griffith

Executive Vice President of Global Markets and PolicyMr. Murdo Gordon

EVP of Research & DevelopmentDr. James E. Bradner M.D.

Executive Vice President of OperationsMr. Esteban Santos

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Miller Derek	SVP, Human Resources	Aug 06 '26	Option Exercise	169.56	3,890	659,574	14,531	Aug 07 06:47 PM
Miller Derek	SVP, Human Resources	Aug 06 '26	Sale	402.54	3,890	1,565,898	12,462	Aug 07 06:47 PM
Grygiel Nancy A.	SVP & CCO	Aug 06 '26	Option Exercise	177.41	2,970	526,906	9,310	Aug 07 06:45 PM
Grygiel Nancy A.	SVP & CCO	Aug 06 '26	Sale	402.16	2,970	1,194,415	7,340	Aug 07 06:45 PM
Derek Miller	Officer	Aug 06 '26	Proposed Sale	404.85	3,890	1,574,866		Aug 06 05:09 PM
Grygiel Nancy A.	Officer	Aug 06 '26	Proposed Sale	447.17	2,670	1,193,940		Aug 06 02:13 PM
Grygiel Nancy A.	SVP & CCO	May 04 '26	Sale	323.73	1,237	400,451	7,009	May 05 08:09 PM
Grygiel Nancy A.	Officer	May 04 '26	Proposed Sale	323.73	1,237	400,450		May 04 04:05 PM
Bradway Robert A	Chairman, CEO and President	Mar 04 '26	Option Exercise	156.35	119,782	18,727,916	576,928	Mar 06 07:32 PM
Santos Esteban	EVP, Operations	Feb 26 '26	Option Exercise	169.19	54,792	9,270,143	107,119	Mar 02 07:20 PM
Santos Esteban	EVP, Operations	Feb 26 '26	Sale	379.12	54,792	20,772,595	76,618	Mar 02 07:20 PM
Santos Esteban	Associate	Feb 26 '26	Proposed Sale	379.12	54,792	20,772,598		Feb 27 12:20 PM
Busch Matthew C.	VP, Finance & CAO	Feb 19 '26	Sale	375.79	1,000	375,790	3,423	Feb 20 07:43 PM
Busch Matthew C.	ASSOCIATED TO AFFILIATE	Feb 19 '26	Proposed Sale	375.00	1,000	375,000		Feb 19 03:55 PM
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Option Exercise	169.70	3,139	532,691	8,864	Nov 21 08:34 PM
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Sale	337.26	3,139	1,058,667	7,225	Nov 21 08:34 PM
Grygiel Nancy A.	Officer	Nov 20 '25	Proposed Sale	337.26	3,139	1,058,667		Nov 20 04:45 PM
Khosla Rachna	SVP, Business Development	Nov 12 '25	Sale	336.24	890	299,256	7,082	Nov 13 07:29 PM
Gordon Murdo	EVP, Global Commercial Ops	Nov 12 '25	Sale	336.83	6,879	2,317,071	41,923	Nov 13 07:28 PM
Gordon Murdo	Officer	Nov 12 '25	Proposed Sale	337.23	6,879	2,319,805		Nov 12 03:02 PM
Khosla Rachna	Officer	Nov 12 '25	Proposed Sale	337.42	890	300,304		Nov 12 02:50 PM
Grygiel Nancy A.	SVP & CCO	Aug 20 '25	Sale	296.99	1,267	376,280	7,209	Aug 22 07:21 PM
Grygiel Nancy A.	Officer	Aug 20 '25	Proposed Sale	294.32	1,267	372,909		Aug 20 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your Finviz experience